Literature DB >> 31978604

Influence of metabolic syndrome on cerebral perfusion and cognition.

Jessica M Livingston1, Matthew W McDonald2, Therese Gagnon1, Matthew S Jeffers2, Mariana Gomez-Smith1, Sabina Antonescu1, Greg O Cron3, Carlie Boisvert4, Baptiste Lacoste5, Dale Corbett6.   

Abstract

Vascular cognitive impairment (VCI) is associated with chronic cerebral hypoperfusion (CCH) and memory deficits, and often occurs concurrently with metabolic syndrome (MetS). Despite their common occurrence, it is unknown whether CCH and MetS act synergistically to exacerbate VCI-associated pathology. Here, using male Sprague-Dawley rats, we examined the effects of a clinically relevant model of adolescent-onset MetS and adult-onset CCH on neuro-vascular outcomes, combining a cafeteria diet with a 2-vessel occlusion (2VO) model. Using longitudinal imaging, histology, and behavioural assessments, we identified several features of MetS and CCH including reduced cerebral blood volume, white matter atrophy, alterations in hippocampal cell density, and memory impairment. Furthermore, we identified a number of significant associations, potentially predictive of MetS and pathophysiological outcomes. White matter volume was positively correlated to HDL cholesterol; hippocampal cell density was negatively correlated to fasted blood glucose; cerebral blood flow and volume was negatively predicted by the combination of 2VO surgery and increased fasted blood glucose. These results emphasize the importance of including comorbid conditions when modeling VCI, and they outline a highly translational preclinical model that could be used to investigate potential interventions to mitigate VCI-associated pathology and cognitive decline.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood glucose; Cerebral blood flow; High-density lipoprotein; Vascular cognitive impairment; White matter

Mesh:

Year:  2020        PMID: 31978604     DOI: 10.1016/j.nbd.2020.104756

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  7 in total

1.  Increased pulse wave velocity is related to impaired working memory and executive function in older adults with metabolic syndrome.

Authors:  Jigar Gosalia; Polly S Montgomery; Shangming Zhang; William A Pomilla; Ming Wang; Menglu Liang; Anna Csiszar; Zoltan Ungvari; Andriy Yabluchanskiy; David N Proctor; Andrew W Gardner
Journal:  Geroscience       Date:  2022-08-18       Impact factor: 7.581

Review 2.  Effect of Combined Antihypertensive and Lipid-Lowering Therapies on Cognitive Function: A New Treatment Strategy?

Authors:  Ze-Min Kuang
Journal:  Cardiol Res Pract       Date:  2020-04-14       Impact factor: 1.866

3.  Relationship Between Metabolic Syndrome and Cognitive Function: A Population-Based Study of Middle-Aged and Elderly Adults in Rural China.

Authors:  Changqing Zhan; Qiao Wang; Jie Liu; Lei Wang; Zongsheng Chen; Hongbo Pang; Jun Tu; Xianjia Ning; Jinghua Wang; Shizao Fei
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-30       Impact factor: 3.168

4.  Modeling subcortical ischemic white matter injury in rodents: unmet need for a breakthrough in translational research.

Authors:  Yuexian Cui; Xuelian Jin; Jun Young Choi; Byung Gon Kim
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

5.  An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment?

Authors:  Stefania Merighi; Tino Emanuele Poloni; Lucia Pelloni; Silvia Pasquini; Katia Varani; Fabrizio Vincenzi; Pier Andrea Borea; Stefania Gessi
Journal:  Front Pharmacol       Date:  2021-03-22       Impact factor: 5.810

Review 6.  Gastrodin and Vascular Dementia: Advances and Current Perspectives.

Authors:  Chujun Deng; Huize Chen; Zeyu Meng; Shengxi Meng
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-12       Impact factor: 2.650

Review 7.  Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?

Authors:  Stefania Merighi; Tino Emanuele Poloni; Anna Terrazzan; Eva Moretti; Stefania Gessi; Davide Ferrari
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.